Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-449c is a member of the microRNA-449 family, a group of small non-coding RNAs involved in the post-transcriptional regulation of gene expression by binding to the 3' untranslated regions of target mRNAs, thereby influencing their stability and translation[1][5]. The miR-449 family comprises miR-449a, miR-449b, and miR-449c, and shares conserved seed sequences with the miR-34 family, forming a superfamily with overlapping functions[1][5]. These microRNAs are crucial regulators of ciliated cell differentiation, cell cycle exit, apoptosis, and mitotic spindle orientation in multiple tissues, including brain, testis, and epithelial tissues[2][5][6]. miR-449c, specifically its -5p form, has been shown to inhibit breast cancer cell proliferation, migration, and invasion by targeting ERBB2 through the JAK/STAT pathway, supporting its role as a tumor suppressor and diagnostic biomarker[3][4]. Dysregulation of miR-449c and its family members is linked with male infertility and several cancers, and their expression levels can serve as sensitive biomarkers in these conditions[2][3]. The molecular mechanisms mediated by miR-449c involve the suppression of Notch and BMP signaling pathways as well as the regulation of key cell cycle and ciliogenesis genes[2].
Post-transcriptional gene silencing (binds 3' UTRs of target mRNAs to control stability and translation)\nRegulates drug response via modulation of fatty acid metabolism (e.g., targeting ACSL4 affecting drug extrusion pump ABCG2)[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-449c (miR-449c).